• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Forestar Real Estate Group LLC

Forestar Real Estate Group LLC

Forestar Group Inc FOR

Last Price$17.00Day Change (%)-0.64%
Open Price$17.00Day Change ($)-0.11
Day Range16.90–17.0852-Week Range15.35–24.03

As of Wed 10/22/2014 08:46 AM EST | USD

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  6. Research
  1. Boston Scientific Announces Results For Third Quarter Ended September 30, 2014

    Boston Scientific Announces Results For Third Quarter Ended September 30, 2014

  2. Target Unveils Plans for Holiday 2014

    Target Unveils Plans for Holiday 2014

  3. TAL Education Group Announces Unaudited Financial Results for the Second Fiscal Quarter Ended August 31, 2014; Changes in Management and Board of Directors

    TAL Education Group Announces Unaudited Financial Results for the Second Fiscal Quarter Ended August 31, 2014; Changes in Management and Board of Directors

  4. River Valley Bancorp Announces Earnings for the Quarter Ended September 30, 2014

    River Valley Bancorp Announces Earnings for the Quarter Ended September 30, 2014

  5. Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015

    Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015

  6. Demand for Digital Interaction in Wealth Management Highest in Asia-Pacific

    Demand for Digital Interaction in Wealth Management Highest in Asia-Pacific

  7. Oman’s Gulf Energy Signs Commercial Order for OriginOil CLEAN-FRAC™ System

    Oman’s Gulf Energy Signs Commercial Order for OriginOil CLEAN-FRAC™ System

  8. UNH-IOL Becomes Official Test Site for G.fast

    UNH-IOL Becomes Official Test Site for G.fast

  9. Santa Cruz County Bank Reports Record Earnings for the Third Quarter Ended September 30, 2014

    Santa Cruz County Bank Reports Record Earnings for the Third Quarter Ended September 30, 2014

  10. Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury

    Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.